Citation Impact
Citing Papers
Comparative analysis reveals no consistent association between the secondary structure of the 3′-untranslated region of dengue viruses and disease syndrome
2006
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Maturation-Dependent HIV-1 Surface Protein Redistribution Revealed by Fluorescence Nanoscopy
2012 StandoutScienceNobel
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
2017 Science
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease
2020
gp340 Expressed on Human Genital Epithelia Binds HIV-1 Envelope Protein and Facilitates Viral Transmission
2007 StandoutNobel
A Protective Role for Dengue Virus-Specific CD8+ T Cells
2009
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice
2017
Size and Charge Characteristics of the Protein Leak in Dengue Shock Syndrome
2004
Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever
2006
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Immunopathological mechanisms in dengue and dengue hemorrhagic fever
2006
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
2017
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus
2017
Virological assessment of hospitalized patients with COVID-2019
2020 StandoutNature
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines
2023 StandoutNobel
Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
2004
Receptors and routes of dengue virus entry into the host cells
2015
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope
2009
Virus-like particles in vaccine development
2010
HIV-1 envelope determinants for cell tropism and chemokine receptor use
1999
Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody
2016
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in human serum using a localized surface plasmon coupled fluorescence fiber-optic biosensor
2009
Zika Virus Associated with Microcephaly
2016 Standout
Immature Dengue Virus: A Veiled Pathogen?
2010
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
A Wolbachia Symbiont in Aedes aegypti Limits Infection with Dengue, Chikungunya, and Plasmodium
2009 Standout
Mouse models of dengue virus infection and disease
2008
A Highly Conserved Arginine in gp120 Governs HIV-1 Binding to Both Syndecans and CCR5 via Sulfated Motifs
2005
Development and characterization of a stable luciferase dengue virus for high-throughput screening
2011
Sepsis and septic shock
2018 Standout
Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic use and save personal protective equipment and swabs
2020
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
2020
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
Human TLR3 recognizes dengue virus and modulates viral replicationin vitro
2008
Zika Virus Outbreak on Yap Island, Federated States of Micronesia
2009 Standout
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
2020
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records
2020 Standout
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase
2005
Dengue
2012 Standout
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
2009
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
A direct RT-qPCR approach to test large numbers of individuals for SARS-CoV-2
2020 StandoutNobel
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
2020 Standout
Localization of Dengue Virus in Naturally Infected Human Tissues, by Immunohistochemistry and In Situ Hybridization
2004
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
2014
A method of layer-by-layer gold nanoparticle hybridization in a quartz crystal microbalance DNA sensing system used to detect dengue virus
2009
A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates
2016
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Dengue Virus Infects Macrophages and Dendritic Cells in a Mouse Model of Infection
2007
Dengue virus life cycle: viral and host factors modulating infectivity
2010 Standout
Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas
2016
Zika virus — reigniting the TORCH
2016
Antibody-mediated neutralization of flaviviruses: A reductionist view
2011
Molecular evolution of dengue viruses: Contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease
2009
SARS-CoV-2 vaccines in development
2020 StandoutNature
The origin, emergence and evolutionary genetics of dengue virus
2003
Higher Infection of Dengue Virus Serotype 2 in Human Monocytes of Patients with G6PD Deficiency
2008
Dengue
2007 Standout
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Selection for Virulent Dengue Viruses Occurs in Humans and Mosquitoes
2004
The Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and Immunoprophylaxis
2017
Kinetics of Viremia and NS1 Antigenemia Are Shaped by Immune Status and Virus Serotype in Adults with Dengue
2011
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro
2012 StandoutNobel
Three-Component and Nonclassical Reaction of Phosphines with Enynes and Aldehydes: Formation of γ-Lactones Featuring α-Phosphorus Ylides
2011
Role of Dendritic Cells in Antibody-Dependent Enhancement of Dengue Virus Infection
2008
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
2019
Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection
2015
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Phosphine Organocatalysis
2018 Standout
The Human Antibody Response to Dengue Virus Infection
2011
Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence
2012
A sulfated metabolite produced bystf3negatively regulates the virulence ofMycobacteriumtuberculosis
2006 StandoutNobel
Immunological serotype interactions and their effect on the epidemiological pattern of dengue
2009
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
2016
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
2020 StandoutScience
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
2010
The Meta-Genome of Sepsis: Host Genetics, Pathogens and the Acute Immune Response
2014
Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007
2008 Standout
QUANTITATIVE ANALYSIS OF DENGUE-2 VIRUS RNA DURING THE EXTRINSIC INCUBATION PERIOD IN INDIVIDUAL AEDES AEGYPTI
2006
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
2016
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
1999 Standout
Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression
2005
Design and Characterization of Stabilized Derivatives of Human CD4D12 and CD4D1
2011 StandoutNobel
Antigenic Variation within the CD4 Binding Site of Human Immunodeficiency Virus Type 1 gp120: Effects on Chemokine Receptor Utilization
2001
Ability of the V3 Loop of Simian Immunodeficiency Virus To Serve as a Target for Antibody-Mediated Neutralization: Correlation of Neutralization Sensitivity, Growth in Macrophages, and Decreased Dependence on CD4
2001
Early Enhanced Expression of Interferon-Inducible Protein-10 (CXCL-10) and Other Chemokines Predicts Adverse Outcome in Severe Acute Respiratory Syndrome
2005
An overview of the determinants of CCR5 and CXCR4 co-receptor function
2001
Prospects for a safe COVID-19 vaccine
2020
EFFECT OF MOSQUITO MIDGUT TRYPSIN ACTIVITY ON DENGUE-2 VIRUS INFECTION AND DISSEMINATION IN AEDES AEGYPTI
2005
Dengue genetic divergence generates within-serotype antigenic variation, but serotypes dominate evolutionary dynamics
2019
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis
2006
Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry
1999
Relationships between CD4 Independence, Neutralization Sensitivity, and Exposure of a CD4-Induced Epitope in a Human Immunodeficiency Virus Type 1 Envelope Protein
2001
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
A Derivate of the Antibiotic Doxorubicin Is a Selective Inhibitor of Dengue and Yellow Fever Virus Replication In Vitro
2010
Antibody-dependent enhancement of severe dengue disease in humans
2017 Science
Discovery of sulfated metabolites in mycobacteria with a genetic and mass spectrometric approach
2002 StandoutNobel
Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease
2019
Coronavirus Infections—More Than Just the Common Cold
2020 Standout
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
2020 Standout
Works of Wei‐Kung Wang being referenced
Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II
2008
Lymphocyte activation and hepatic cellular infiltration in immunocompetent mice infected by dengue virus
2004
Interaction between HIV Type 1 Glycoprotein 120 and CXCR4 Coreceptor Involves a Highly Conserved Arginine Residue in Hypervariable Region 3
2000
In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
2011
Temporal Relationship of Viral Load, Ribavirin, Interleukin (IL)–6, IL‐8, and Clinical Progression in Patients with Severe Acute Respiratory Syndrome
2004
Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors
2008
Slower Rates of Clearance of Viral Load and Virus‐Containing Immune Complexes in Patients with Dengue Hemorrhagic Fever
2006
Immunofluorescence Assay for Detection of the Nucleocapsid Antigen of the Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus in Cells Derived from Throat Wash Samples of Patients with SARS
2005
Sequence Diversity of the Capsid Gene and the Nonstructural Gene NS2B of Dengue-3 Virus in Vivo
2002
The C-terminal helical domain of dengue virus precursor membrane protein is involved in virus assembly and entry
2010
Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan1
2003
Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay
2012
Strategically examining the full-genome of dengue virus type 3 in clinical isolates reveals its mutation spectra
2005
Preparation and anti-HIV activities of retrojusticidin B analogs and azalignans
2004
Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
2014
Analysis of Cross-Reactive Antibodies Recognizing the Fusion Loop of Envelope Protein and Correlation with Neutralizing Antibody Titers in Nicaraguan Dengue Cases
2013
High Levels of Plasma Dengue Viral Load during Defervescence in Patients with Dengue Hemorrhagic Fever: Implications for Pathogenesis
2003
Using the rate of bacterial clearance determined by real-time polymerase chain reaction as a timely surrogate marker to evaluate the appropriateness of antibiotic usage in critical patients with Acinetobacter baumannii bacteremia*
2012
Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2
2007
High Levels of mecA DNA Detected by a Quantitative Real-Time PCR Assay Are Associated with Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia
2009
Detection of Dengue Virus Replication in Peripheral Blood Mononuclear Cells from Dengue Virus Type 2-Infected Patients by a Reverse Transcription-Real-Time PCR Assay
2002
The Length of and Nonhydrophobic Residues in the Transmembrane Domain of Dengue Virus Envelope Protein Are Critical for Its Retention and Assembly in the Endoplasmic Reticulum
2010
Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests
2017
High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection
2013
CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120
1998
Quantitative Competitive Reverse Transcription-PCR for Quantification of Dengue Virus RNA
2000
Detection of Severe Acute Respiratory Syndrome Coronavirus RNA in Plasma during the Course of Infection
2005
The Helical Domains of the Stem Region of Dengue Virus Envelope Protein Are Involved in both Virus Assembly and Entry
2011
Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies
2015
Dengue Type 3 Virus in Plasma Is a Population of Closely Related Genomes: Quasispecies
2002
Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: Therapeutic and prophylactic implications
1999